Your browser doesn't support javascript.
loading
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105.
Liu, Yingmiao; Starr, Mark D; Brady, John C; Rushing, Christel; Pang, Herbert; Adams, Bonne; Alvarez, Delia; Theuer, Charles P; Hurwitz, Herbert I; Nixon, Andrew B.
Afiliação
  • Liu Y; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Starr MD; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Brady JC; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Rushing C; Duke Department of Biostatistics and Bioinformatics, Durham, North Carolina.
  • Pang H; Duke Department of Biostatistics and Bioinformatics, Durham, North Carolina.
  • Adams B; School of Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
  • Alvarez D; Tracon Pharmaceuticals, Inc., San Diego, California.
  • Theuer CP; Tracon Pharmaceuticals, Inc., San Diego, California.
  • Hurwitz HI; Tracon Pharmaceuticals, Inc., San Diego, California.
  • Nixon AB; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Mol Cancer Ther ; 17(10): 2248-2256, 2018 10.
Article em En | MEDLINE | ID: mdl-29997150
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Bevacizumab / Endoglina / Antineoplásicos Imunológicos / Anticorpos Monoclonais / Neoplasias Limite: Female / Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Bevacizumab / Endoglina / Antineoplásicos Imunológicos / Anticorpos Monoclonais / Neoplasias Limite: Female / Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos